Edition:
United Kingdom

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

0.49USD
16 Jul 2019
Change (% chg)

-- (--)
Prev Close
$0.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
33,435
52-wk High
$7.39
52-wk Low
$0.47

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.029
Sep '18 0.00 -0.052
Jun '18 0.00 -0.046
Mar '18 0.00 -0.028
FY 2017 Dec '17 0.00 -0.028
Sep '17 0.00 -0.070
Jun '17 0.00 -0.042
Mar '17 0.00 -0.137
 
*Note: Units in Millions ofShekel
**Note: Units in Shekel

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.67 34.23
P/E High - Last 5 Yrs. -- 166.94 54.34
P/E Low - Last 5 Yrs. -- 52.71 28.30
Beta 2.09 1.29 0.99
Price to Sales (TTM) -- 41.72 10.86
Price to Book (MRQ) 15.51 11.92 4.40
Price to Tangible Book (MRQ) 13.39 16.83 5.11
Price to Cash Flow (TTM) -- 62.77 24.08
% Owned Institutions -- 3.31 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.65
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.88 6.79
Payout Ratio(TTM) -- 2.16 47.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 66.65 14.80
Sales (TTM) vs TTM 1 Yr. Ago -- 49.02 8.30
Sales - 5 Yr. Growth Rate -- 33.21 9.58
EPS (MRQ) vs Qtr. 1 Yr. Ago -2.71 -6.72 17.64
EPS (TTM) vs TTM 1 Yr. Ago 44.00 -- --
EPS - 5 Yr. Growth Rate -- 22.39 7.08
Capital Spending - 5 Yr. Growth Rate 99.04 26.20 7.86

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.78 2.53
Current Ratio (MRQ) 3.80 3.89 3.53
LT Debt to Equity (MRQ) 0.00 8.03 12.99
Total Debt to Equity (MRQ) 0.00 21.12 18.12
Interest Coverage (TTM) -6.45 31.73 14.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 21.88 50.16
Gross Margin - 5 Yr. Avg. -- 58.98 51.34
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -12.63 16.42
Operating Margin (TTM) -- -125.83 -10.70
Operating Margin - 5 Yr. Avg. -- -28.80 11.90
Pre-Tax Margin (TTM) -- -127.42 -11.09
Pre-Tax Margin - 5 Yr. Avg. -- -33.87 16.01
Net Profit Margin (TTM) -- -133.07 -14.89
Net Profit Margin - 5 Yr. Avg. -- -38.79 11.35
Effective Tax Rate (TTM) -- 17.14 20.56
Effective Tax Rate - 5 Yr. Avg. -- 18.80 24.44

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 9,563,801 870,638,984
Net Income/Employee (TTM) -- 2,021,678 101,885,986
Receivable Turnover (TTM) -- 11.96 5.89
Inventory Turnover (TTM) -- 2.42 3.65
Asset Turnover (TTM) 0.00 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -78.86 6.30 10.21
Return on Assets - 5 Yr. Avg. -76.37 6.08 11.14
Return on Investment (TTM) -95.75 7.62 12.65
Return on Investment - 5 Yr. Avg. -88.29 7.93 14.12
Return on Equity (TTM) -122.73 8.05 17.19
Return on Equity - 5 Yr. Avg. -99.99 8.86 15.50
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 38.35 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellect Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.